Autologous chemically induced liver progenitor cell transplantation ameliorates steatosis and fibrosis in a preclinical miniature pig model of metabolic dysfunction–associated fatty liver disease: A pilot study
Cell Transplantation · 2026
DOI: 10.1177/09636897261446732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Transplantation, 2026. Verfasst von Takanobu Hara und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan. Hauptthemen laut MEDLINE: Stem Cell Transplantation, Fatty Liver, Liver, Stem Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disorder and can progress to steatohepatitis and fibrosis; although approved pharmacotherapies for metabolic dysfunction–associated steatohepatitis (MASH) with fibrosis remain limited. Autologous chemically induced liver progenitor (CLiP) cells, generated from mature hepatocytes without genetic modification, have shown therapeutic promise in rodents, but their efficacy has not been tested in large animals. Six female Clawn miniature pigs (15–42 kg) were fed a high-fat, high-cholesterol diet to induce MASLD with biopsy-proven fibrosis (Brunt stage ≥1). Animals were assigned to CLiP transplantation ( n = 3) or saline control ( n = 3). Autologous CLiPs (5 × 10 7 ) were generated from laparoscopically resected liver wedges, expanded ex vivo , and infused intraportally. Safety was assessed by monitoring, liver function tests, and lipid profiles. Efficacy was evaluated 1 month later by blinded histology and immunohistochemistry. CLiP transplantation was feasible and well tolerated. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) showed minimal changes in both groups, but total cholesterol and triglycerides decreased in treated pigs and increased in controls. Histologically, two of three CLiP-treated livers regressed from Brunt stage 1 to 0, with resolution of steatosis and reduced stellate cell activation, whereas controls showed no regression. These findings support CLiP therapy as a regenerative option for MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japan.
- Department of Molecular and Cellular Medicine, Tokyo Medical University, Shinjuku-ku, Japan.
ORCID-Profile: Takanobu Hara, Daisuke Miyamoto, Hajime Matsushima, Akihiko Soyama, Susumu Eguchi
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Hara, T., Maruya, Y., Miyamoto, D., Fukumoto, M., Imamura, H., Matsushima, H., Soyama, A., Adachi, T., Ochiya, T., & Eguchi, S. (2026). Autologous chemically induced liver progenitor cell transplantation ameliorates steatosis and fibrosis in a preclinical miniature pig model of metabolic dysfunction–associated fatty liver disease: A pilot study. Cell Transplantation. https://doi.org/10.1177/09636897261446732
Vancouver
Hara T, Maruya Y, Miyamoto D, Fukumoto M, Imamura H, Matsushima H, et al. Autologous chemically induced liver progenitor cell transplantation ameliorates steatosis and fibrosis in a preclinical miniature pig model of metabolic dysfunction–associated fatty liver disease: A pilot study. Cell Transplantation. 2026. doi:10.1177/09636897261446732
BibTeX
@article{Hara2026,
author = {Hara, Takanobu and Maruya, Yasuhiro and Miyamoto, Daisuke and Fukumoto, Masayuki and Imamura, Hajime and Matsushima, Hajime and Soyama, Akihiko and Adachi, Tomohiko and Ochiya, Takahiro and Eguchi, Susumu},
title = {Autologous chemically induced liver progenitor cell transplantation ameliorates steatosis and fibrosis in a preclinical miniature pig model of metabolic dysfunction–associated fatty liver disease: A pilot study},
journal = {Cell Transplantation},
year = {2026},
doi = {10.1177/09636897261446732}
}
EUVIMED